[Remarks on the present-day pharmacotherapy of late pregnancy toxemias].
D001463:Barbiturates / Q000009:adverse effects; D001794:Blood Pressure; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D004357:Drug Synergism; D004461:Eclampsia / Q000188:drug therapy; D005260:Female; D005730:Ganglionic Blockers / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000188:drug therapy*; D011247:Pregnancy; D011526:Protoveratrines / Q000627:therapeutic use; D012110:Reserpine / Q000009:adverse effects / Q000627:therapeutic use; D013431:Sulfates / Q000627:therapeutic use
D001463:Barbiturates; D004232:Diuretics; D005730:Ganglionic Blockers; D006834:Hydrazines; D011526:Protoveratrines; D013431:Sulfates; D012110:Reserpine; D008274:Magnesium
Uwagi o współczesnej farmakoterapii późnych zatruć ciazowych.